IBDEI2GO ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41743,0)
 ;;=M05.79^^159^2010^148
 ;;^UTILITY(U,$J,358.3,41743,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41743,1,3,0)
 ;;=3^Rheumatoid Arthritis of Multiple Sites
 ;;^UTILITY(U,$J,358.3,41743,1,4,0)
 ;;=4^M05.79
 ;;^UTILITY(U,$J,358.3,41743,2)
 ;;=^5010022
 ;;^UTILITY(U,$J,358.3,41744,0)
 ;;=M06.00^^159^2010^155
 ;;^UTILITY(U,$J,358.3,41744,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41744,1,3,0)
 ;;=3^Rheumatoid Arthritis w/o Rhematoid Factor,Unspec Site
 ;;^UTILITY(U,$J,358.3,41744,1,4,0)
 ;;=4^M06.00
 ;;^UTILITY(U,$J,358.3,41744,2)
 ;;=^5010047
 ;;^UTILITY(U,$J,358.3,41745,0)
 ;;=M06.30^^159^2010^158
 ;;^UTILITY(U,$J,358.3,41745,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41745,1,3,0)
 ;;=3^Rheumatoid Nodule,Unspec Site
 ;;^UTILITY(U,$J,358.3,41745,1,4,0)
 ;;=4^M06.30
 ;;^UTILITY(U,$J,358.3,41745,2)
 ;;=^5010096
 ;;^UTILITY(U,$J,358.3,41746,0)
 ;;=M06.4^^159^2010^48
 ;;^UTILITY(U,$J,358.3,41746,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41746,1,3,0)
 ;;=3^Inflammatory Polyarthropathy
 ;;^UTILITY(U,$J,358.3,41746,1,4,0)
 ;;=4^M06.4
 ;;^UTILITY(U,$J,358.3,41746,2)
 ;;=^5010120
 ;;^UTILITY(U,$J,358.3,41747,0)
 ;;=M06.39^^159^2010^157
 ;;^UTILITY(U,$J,358.3,41747,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41747,1,3,0)
 ;;=3^Rheumatoid Nodule,Mult Sites
 ;;^UTILITY(U,$J,358.3,41747,1,4,0)
 ;;=4^M06.39
 ;;^UTILITY(U,$J,358.3,41747,2)
 ;;=^5010119
 ;;^UTILITY(U,$J,358.3,41748,0)
 ;;=M15.0^^159^2010^121
 ;;^UTILITY(U,$J,358.3,41748,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41748,1,3,0)
 ;;=3^Primary Generalized Osteoarthritis
 ;;^UTILITY(U,$J,358.3,41748,1,4,0)
 ;;=4^M15.0
 ;;^UTILITY(U,$J,358.3,41748,2)
 ;;=^5010762
 ;;^UTILITY(U,$J,358.3,41749,0)
 ;;=M06.9^^159^2010^156
 ;;^UTILITY(U,$J,358.3,41749,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41749,1,3,0)
 ;;=3^Rheumatoid Arthritis,Unspec
 ;;^UTILITY(U,$J,358.3,41749,1,4,0)
 ;;=4^M06.9
 ;;^UTILITY(U,$J,358.3,41749,2)
 ;;=^5010145
 ;;^UTILITY(U,$J,358.3,41750,0)
 ;;=M16.0^^159^2010^124
 ;;^UTILITY(U,$J,358.3,41750,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41750,1,3,0)
 ;;=3^Primary Osteoarthritis of Hip,Bilateral
 ;;^UTILITY(U,$J,358.3,41750,1,4,0)
 ;;=4^M16.0
 ;;^UTILITY(U,$J,358.3,41750,2)
 ;;=^5010769
 ;;^UTILITY(U,$J,358.3,41751,0)
 ;;=M16.11^^159^2010^133
 ;;^UTILITY(U,$J,358.3,41751,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41751,1,3,0)
 ;;=3^Primary Osteoarthritis of Right Hip
 ;;^UTILITY(U,$J,358.3,41751,1,4,0)
 ;;=4^M16.11
 ;;^UTILITY(U,$J,358.3,41751,2)
 ;;=^5010771
 ;;^UTILITY(U,$J,358.3,41752,0)
 ;;=M16.12^^159^2010^127
 ;;^UTILITY(U,$J,358.3,41752,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41752,1,3,0)
 ;;=3^Primary Osteoarthritis of Left Hip
 ;;^UTILITY(U,$J,358.3,41752,1,4,0)
 ;;=4^M16.12
 ;;^UTILITY(U,$J,358.3,41752,2)
 ;;=^5010772
 ;;^UTILITY(U,$J,358.3,41753,0)
 ;;=M17.0^^159^2010^123
 ;;^UTILITY(U,$J,358.3,41753,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41753,1,3,0)
 ;;=3^Primary Osteoarthritis of Bilateral Knees
 ;;^UTILITY(U,$J,358.3,41753,1,4,0)
 ;;=4^M17.0
 ;;^UTILITY(U,$J,358.3,41753,2)
 ;;=^5010784
 ;;^UTILITY(U,$J,358.3,41754,0)
 ;;=M17.11^^159^2010^134
 ;;^UTILITY(U,$J,358.3,41754,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41754,1,3,0)
 ;;=3^Primary Osteoarthritis of Right Knee
 ;;^UTILITY(U,$J,358.3,41754,1,4,0)
 ;;=4^M17.11
 ;;^UTILITY(U,$J,358.3,41754,2)
 ;;=^5010786
 ;;^UTILITY(U,$J,358.3,41755,0)
 ;;=M17.12^^159^2010^128
 ;;^UTILITY(U,$J,358.3,41755,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41755,1,3,0)
 ;;=3^Primary Osteoarthritis of Left Knee
 ;;^UTILITY(U,$J,358.3,41755,1,4,0)
 ;;=4^M17.12
